WRRisk

WRRisk

Whiterabbit.ai
+
+

Related Products

  • MedRight
    22 Ratings
    Visit Website
  • Aesthetic Insight
    10 Ratings
    Visit Website
  • RXNT
    551 Ratings
    Visit Website
  • FrameworkLTC
    48 Ratings
    Visit Website
  • Valant Behavioral Health EHR
    335 Ratings
    Visit Website
  • AestheticsPro
    684 Ratings
    Visit Website
  • Opus
    93 Ratings
    Visit Website
  • AdvancedMD
    2 Ratings
    Visit Website
  • DoctorConnect
    84 Ratings
    Visit Website
  • NovusMED
    1 Rating
    Visit Website

About

Omda’s oncology medication management solution, Omda Cytodose, uses clinically validated protocols and patient parameters to secure optimal and safer treatment for oncology patients. The system strengthens all aspects of medical care for cancer patients, with a holistic and coherent treatment flow between doctors, pharmacists, and nurses. Omda Cytodose provides support for all adult and pediatric cancers and is suitable for every type of medical cancer treatment, including chemotherapy, immunotherapy, hormone therapy, as well as supportive medication. Originally developed by clinicians at Norway’s leading cancer center, and launched in 2001, Omda Cytodose is widely used by healthcare regions across the Nordics, with millions of orders completed. It has a 15-year record of stability, reliability, and safety. Omda Cytodose is configured with clinically validated chemotherapy protocols based on national and international guidelines.

About

The product assigns a risk rating to a patient to drive a digital personalized screening plan for more consistent follow-up recommendations and more accurate diagnosis. This approach helps to catch cancers in the women that are at the greatest risk. WRRisk serves as a fully digital breast cancer risk assessment combining patient completed digital forms with a density assessment to provide a unified risk scorecard. WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation. The product equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime risk as well as risk-based on runner-up density.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Clinics interested in a solution to optimize their oncology treatments

Audience

Clinics in need of a clinical decision support software for breast cancer risk assessment

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

Omda
Founded: 1999
Norway
omda.com/solutions/medication-management/omda-cytodose/

Company Information

Whiterabbit.ai
Founded: 2017
United States
www.whiterabbit.ai/products/wrrisk

Alternatives

Alternatives

WRDensity

WRDensity

Whiterabbit.ai
Progeny Clinical

Progeny Clinical

Progeny Software

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim Omda Cytodose and update features and information
Claim Omda Cytodose and update features and information
Claim WRRisk and update features and information
Claim WRRisk and update features and information